REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $731,665 | +92.4% | 7,176 | +71.6% | 0.00% | – |
| Q1 2023 | $380,318 | +10.7% | 4,183 | -53.7% | 0.00% | – |
| Q4 2022 | $343,544 | +30.1% | 9,043 | +244.4% | 0.00% | – |
| Q3 2021 | $264,000 | -29.2% | 2,626 | -0.3% | 0.00% | – |
| Q2 2021 | $373,000 | +37.1% | 2,633 | -3.6% | 0.00% | – |
| Q1 2021 | $272,000 | -6.2% | 2,731 | +16.4% | 0.00% | – |
| Q4 2020 | $290,000 | +7.4% | 2,347 | +35.5% | 0.00% | – |
| Q2 2020 | $270,000 | -21.7% | 1,732 | +2.5% | 0.00% | – |
| Q4 2019 | $345,000 | – | 1,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |